Literature DB >> 7142708

Depression of natural killer activity and mitogen responsiveness in mice treated with pristane.

Y R Freund, P B Blair.   

Abstract

In BALB/c mice, the injection of pristane resulted in a severe decrease in splenic T and B cell proliferative responses to mitogens and in a depression of natural killer (NK) activity. The effects of T and B cells, which persisted for at least 5 mo, were mediated by different mechanisms. T cell responsiveness to PHA dropped significantly below control levels 1 wk after the first of three monthly pristane injections, whereas B cell proliferation in response to LPS did not decrease until 4 wk after the first injection. The removal of plastic-adherent suppressor cells completely restored T cell proliferative capacity, but had no effect on B cells. NK activity against YAC-1 tumor targets was reduced 1 mo after the first pristane injection and remained depressed for at least 3 mo. This depression was not mediated by plastic-adherent suppressor cells. Spleen cell NK activity from pristane-treated mice could not be augmented by the interferon inducer Poly I:C to the same extent as that of control mice. This suggests an effect of pristane on either pre-NK cells or on cells that regulate NK activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7142708

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Characterization of human larynx carcinoma cell lines HLaC'79 and HLaC'82: a common origin but diverged malignancies.

Authors:  A M Tomson; J Scholma; T Dijkhuizen; A P Wijnakker; M van der Werf; K M de Jong; M B van Leeuwen; J G Koning
Journal:  Clin Exp Metastasis       Date:  1995-09       Impact factor: 5.150

Review 2.  Human monoclonal antibodies.

Authors:  S P Cole; B G Campling; T Atlaw; D Kozbor; J C Roder
Journal:  Mol Cell Biochem       Date:  1984-06       Impact factor: 3.396

3.  Changes in the DNA of lymphocytes from pristane treated rats.

Authors:  L R Garrett; K L Bost; T M Buttke; M A Cuchens
Journal:  Agents Actions       Date:  1987-02

4.  Immunomodulatory strategies prevent the development of autoimmune emphysema.

Authors:  Masayuki Hanaoka; Mark R Nicolls; Andrew P Fontenot; Donatas Kraskauskas; Douglas G Mack; Adelheid Kratzer; Jonas Salys; Vita Kraskauskiene; Nana Burns; Norbert F Voelkel; Laimute Taraseviciene-Stewart
Journal:  Respir Res       Date:  2010-12-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.